Su Hsien Lim, MD

Assistant Professor of Medicine (Medical Oncology)

DownloadHi-Res Photo

Are You a Patient?

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

Contact Info

suhsien.lim@yale.edu

About

Titles

Assistant Professor of Medicine (Medical Oncology)

Appointments

Medical Oncology
Assistant Professor
Primary
Medical Oncology

Internal Medicine
Medical Oncology
Subset Medical Oncology Faculty
Yale Cancer Center
Yale Medicine

Education & Training

Fellowship: Memorial Sloan Kettering Cancer Center (2008)

Residency: Bellevue Hospital (2004)

MD: New York University School of Medicine (2001)

Research

Publications

2007

Doxorubicin and concurrent radiotherapy for anaplastic thyroid cancer: We need to do better
Lim S, Lee N, Fury M, Ghossein R, Shaha A, Wolden S, Pfister D. Doxorubicin and concurrent radiotherapy for anaplastic thyroid cancer: We need to do better. Journal Of Clinical Oncology 2007, 25: 16506-16506. DOI: 10.1200/jco.2007.25.18_suppl.16506.
Peer-Reviewed Original Research
Concepts

Clinical Trials

Current Trials

Phase 2 Study of Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory CD30 Positive T-cell Lymphoma
HIC ID2000029793RoleSub InvestigatorPrimary Completion Date04/30/2028
Recruiting Participants
Lymphoma
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
HIC ID2000032279RoleSub InvestigatorPrimary Completion Date12/31/2033
Recruiting Participants
Prostate Cancer
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
HIC ID2000032879RoleSub InvestigatorPrimary Completion Date12/31/2026
Recruiting Participants
Lung Cancer
A Randomized, Phase IIB, Multicenter, Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in Patients With Relapse or Refractory Peripheral T-cell Lymphoma (PTCL)
HIC ID2000030190RoleSub InvestigatorPrimary Completion Date06/02/2026
Recruiting Participants
Lymphoma
Novel Combination of Belantamab Mafodotin and Elotuzumab to Enhance Therapeutic Efficacy in Multiple Myeloma
HIC ID2000028918RoleSub InvestigatorPrimary Completion Date01/01/2025
Recruiting Participants
Myeloma

See All Current Clinical Trials

Clinical Care

Overview

Medical Oncology; Hematology & Oncology

Fact Sheets

Thrombocytopenia
Learn More on Yale Medicine
Myeloproliferative Neoplasms
Learn More on Yale Medicine
Myelodysplastic/Myeloproliferative Neoplasms
Learn More on Yale Medicine
Hormonal Therapy for Cancer
Learn More on Yale Medicine

See All Fact Sheets On Yale Medicine

Yale Medicine News

See All News On Yale Medicine

View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.

View Doctor Profile

News

News

Get In Touch

Contacts

Email

suhsien.lim@yale.edu

Appointment Number

Clinic Fax Number

Locations

Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
See Patient Care Locations